High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

Clinical trial NCT05053555 · RECRUITING

Trial details

NCT number: NCT05053555
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Liver Malignant Tumors Cholangiocarcinoma Metastatic Pancreatic Cancer Melanoma

Start date: 2022-04-24
Primary completion: 2027-01-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.